Merus NV
MRUS90.000USD
0.0000.00%
終値 02/06, 16:00（ET）15分遅れの株価
6.83B時価総額
損失額直近12ヶ月PER
詳細情報 Merus NV 企業名
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.
Merus NVの企業情報
企業コードMRUS
会社名Merus NV
上場日May 19, 2016
最高経営責任者「CEO」Lundberg (Sven Ante)
従業員数260
証券種類Ordinary Share
決算期末May 19
本社所在地Yalelaan 62
都市UTRECHT
証券取引所NASDAQ OMX - NASDAQ BASIC
国Netherlands
郵便番号3584 CM
電話番号310302538800
ウェブサイトhttps://merus.nl/
企業コードMRUS
上場日May 19, 2016
最高経営責任者「CEO」Lundberg (Sven Ante)
Merus NVの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Sven Ante (Bill) Lundberg, M.D.
Dr. Sven Ante (Bill) Lundberg, M.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
168.44K
-30297.00%
Mr. Mark T. Iwicki
Mr. Mark T. Iwicki
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Peter B. Silverman, J.D.
Mr. Peter B. Silverman, J.D.
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
--
--
Dr. Anand Mehra, M.D.
Dr. Anand Mehra, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Leonard (Len) Kanavy
Mr. Leonard (Len) Kanavy
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Paolo Pucci
Mr. Paolo Pucci
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Victor Sandor, M.D.
Dr. Victor Sandor, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Sherri Spear
Ms. Sherri Spear
Investor Relations and Corporate Communications
Investor Relations and Corporate Communications
--
--
Dr. Maxine Gowen, Ph.D.
Dr. Maxine Gowen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Sven Ante (Bill) Lundberg, M.D.
Dr. Sven Ante (Bill) Lundberg, M.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
168.44K
-30297.00%
Mr. Mark T. Iwicki
Mr. Mark T. Iwicki
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Peter B. Silverman, J.D.
Mr. Peter B. Silverman, J.D.
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
--
--
Dr. Anand Mehra, M.D.
Dr. Anand Mehra, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Leonard (Len) Kanavy
Mr. Leonard (Len) Kanavy
Non-Executive Independent Director
Non-Executive Independent Director
--
--
収益内訳
会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Sat, Jan 3
更新時刻: Sat, Jan 3
株主統計
種類
株主統計
株主統計
比率
Paradigm BioCapital Advisors LP
5.77%
Avoro Capital Advisors LLC
4.67%
Commodore Capital LP
4.65%
Deerfield Management Company, L.P.
4.02%
HBK Investments, L.P.
3.76%
他の
77.14%
株主統計
株主統計
比率
Paradigm BioCapital Advisors LP
5.77%
Avoro Capital Advisors LLC
4.67%
Commodore Capital LP
4.65%
Deerfield Management Company, L.P.
4.02%
HBK Investments, L.P.
3.76%
他の
77.14%
種類
株主統計
比率
Hedge Fund
39.38%
Investment Advisor/Hedge Fund
27.56%
Investment Advisor
13.49%
Research Firm
2.54%
Corporation
1.93%
Private Equity
1.78%
Venture Capital
1.47%
Pension Fund
0.56%
Bank and Trust
0.49%
他の
10.81%
機関投資家保有株
更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
498
69.89M
92.15%
-15.18M
2025Q3
434
77.32M
101.98%
-5.60M
2025Q2
411
75.46M
99.77%
-10.50M
2025Q1
420
74.82M
101.12%
-10.15M
2024Q4
398
74.69M
108.18%
-7.45M
2024Q3
373
72.99M
107.03%
-6.71M
2024Q2
355
69.91M
103.77%
+7.77M
2024Q1
315
57.35M
97.63%
-5.32M
2023Q4
282
57.36M
99.41%
-5.55M
2023Q3
268
57.60M
100.50%
+2.76M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Paradigm BioCapital Advisors LP
4.37M
5.77%
+91.82K
+2.14%
Sep 30, 2025
Avoro Capital Advisors LLC
3.54M
4.67%
+386.94K
+12.26%
Sep 30, 2025
Commodore Capital LP
3.52M
4.65%
--
--
Sep 30, 2025
Deerfield Management Company, L.P.
3.05M
4.02%
-337.71K
-9.98%
Sep 30, 2025
HBK Investments, L.P.
2.85M
3.76%
+2.85M
--
Sep 30, 2025
Westfield Capital Management Company, L.P.
2.13M
2.81%
+90.10K
+4.41%
Sep 30, 2025
RTW Investments L.P.
2.03M
2.67%
-1.98M
-49.38%
Sep 30, 2025
Fidelity Management & Research Company LLC
1.94M
2.55%
-4.28M
-68.87%
Sep 30, 2025
Woodline Partners LP
1.67M
2.21%
+131.27K
+8.51%
Sep 30, 2025
Glazer Capital, LLC
1.62M
2.13%
+1.62M
--
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Tue, Dec 2
更新時刻: Tue, Dec 2
銘柄名
比率
AltShares Merger Arbitrage ETF
3.3%
NYLI Merger Arbitrage ETF
3.1%
ALPS Medical Breakthroughs ETF
2.89%
Goldman Sachs Hedge Industry VIP ETF
2.75%
ProShares Merger ETF
2.74%
First Trust IPOX Europe Equity Opportunities ETF
2.61%
Tema Oncology ETF
2.61%
Invesco Dorsey Wright Healthcare Momentum ETF
1.4%
Harbor Health Care ETF
1.29%
AltShares Event-Driven ETF
1.23%
詳細を見る
AltShares Merger Arbitrage ETF
比率3.3%
NYLI Merger Arbitrage ETF
比率3.1%
ALPS Medical Breakthroughs ETF
比率2.89%
Goldman Sachs Hedge Industry VIP ETF
比率2.75%
ProShares Merger ETF
比率2.74%
First Trust IPOX Europe Equity Opportunities ETF
比率2.61%
Tema Oncology ETF
比率2.61%
Invesco Dorsey Wright Healthcare Momentum ETF
比率1.4%
Harbor Health Care ETF
比率1.29%
AltShares Event-Driven ETF
比率1.23%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
